March 24, 2026

ASH 2025: Myelofibrosis Roundup

For myelofibrosis, the treatment landscape is poised for change as new targets have emerged, and treatments are evolving beyond the standard Janus kinase (JAK) inhibitors. Novel therapies are being pa...

The ASCO Post

March 24, 2026

SIOG 2025: Celebrating 25 Years of Leadership in Geriatric Oncology

The 25th Annual Conference of the International Society of Geriatric Oncology (SIOG) convened in Ghent, Belgium, from November 20 to 22, 2025, marking a quarter-century of international collaboration ...

The ASCO Post

March 24, 2026

No Recurrence-Free Survival Benefit With Adjuvant Pembrolizumab in Hepatocellular Carcinoma

Recurrence-free survival was similar between adjuvant therapy with the PD-1 inhibitor pembrolizumab and placebo in patients with hepatocellular carcinoma who achieved a complete radiologic response af...

The ASCO Post

March 24, 2026

Activity Observed with Novel KRAS Inhibitor in Pancreatic Cancer

A novel KRAS G12D inhibitor produced disease control in almost 80% of patients with heavily pretreated advanced or metastatic KRAS G12D–mutated pancreatic cancer in an early-phase study reported at th...

The ASCO Post

March 24, 2026

Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer

The combination of the NECTIN4-directed antibody drug conjugate enfortumab vedotin-ejfv and the immunotherapy drug pembrolizumab is the established first-line standard-of-care treatment for patients w...

The ASCO Post

March 20, 2026

Lawrence Blacher, M.D., Memorial Lecture: Advancing the Fight Against Cardiac Amyloidosis: A 2026 Update

Please join us to hear Omar F. Abou-Ezzeddine, M.D.C.M., M.S., at the Lawrence Blacher, M.D., Memorial Lecture, where he will provide a 2026 update on amyloid cardiomyopathy, highlighting current diagnostic strategies, emerging therapies, and practical approaches to patient care.

Baptist Health South Florida

March 17, 2026

2025 SABCS Highlights: Targeted Therapies for Advanced Breast Cancer

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH, discuss the CAPItello-291, VIKTORIA-1, and STX-478 trials which were presented at the 2025 San Antonio Breast Cancer Symposium

Dana-Farber

March 13, 2026

Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference

Register for the Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual meeting, taking place on April 25-26 in Buffalo, NY.

Roswell Park Comprehensive Cancer Center

March 05, 2026

How AI Is Ushering in a New Era in Cancer Care

On October 30, 2025, Google Cloud held its second annual Cancer AI Symposium to explore how artificial intelligence (AI) is advancing cancer research, diagnosis, and treatment, in unparalleled ways. H...

The ASCO Post

February 27, 2026

United in Care at JADPRO Live 2025

JADPRO Live 2023 showcased groundbreaking collaborations in oncology education and practice, uniting healthcare professionals to enhance cancer care.

JADPRO